Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Nuklearmedizin ; 15(4): 160-3, 1976 Aug.
Article in English | MEDLINE | ID: mdl-980792

ABSTRACT

Ten patients with known malignant intra-thoracic tumors and no evidence of superior vena cava syndrome were evaluated by means of scintillation camera superior venacavograms. Four of the ten patients proved to have unsuspected involvement of the superior vena cava or its tributaries. The scintillation camer superior venacavogram provides a quick, safe, and accurate method of evaluating the patency of the SVC and its tributaries. We suggest that it should be routinely performed on all patients prior to beginning radiation therapy for malignant intra-thoracic tumors.


Subject(s)
Radionuclide Imaging , Thoracic Neoplasms/complications , Vena Cava, Superior , Humans , Methods , Middle Aged , Patient Care Planning , Technetium , Thoracic Neoplasms/radiotherapy , Vascular Diseases/diagnosis
2.
J Nucl Med ; 16(2): 109-15, 1975 Feb.
Article in English | MEDLINE | ID: mdl-162949

ABSTRACT

Thekinetic of 99mTc-labeled pyrophosphate were compared with those of polyphosphate in ten patients in a combined study. Both agents cleared from the blood in a biexpoential fashion. The clearance half-time of Exponent I was the same for both and was shorter than the clearance half-time of Exponent ii. Urinary excretion of both agents was the same during the first hour but during the next 3 hr Tc-pyrophosphate cleared at a slightly more rapid rate, resulting in lower blood background radioactivity. Both agents were bound loosely to plasma proteins, mainly to globulin fractions. The sensitivity of lesion detection was similar for both. Excellent bone images were obtained with both agents. The images with Tc-pyrophosphatewere consistently superior owing to the low blood background and they took less time to accumulate an identical number of counts from identical regions. With the amount of 99mTc-complex used, no hyocalcemia or tetany was noted, nor was there any significant effect on 1-hr serum levels of inorganic phosphours and alkaline phosphatase. Four hours after injection, 9.5% of the dose of Tc-pyrophosphate was circulating in blood, 31.7% was excreted in urine, and the remaining 58.8% was taken up by bone and other tissues. The corresponding values with Tc-polyphosphate were 12.5% in blood, 29.0% in urine, and 58.5% in bone and other tissues. Among the soft tissues, the genitourinary system is most consistently visualized. It is concluded that both Tc-pyroposphate and Tc-polyphosphate are excellent skeletal-imaging agents and that Tc-pyrophosphate appears slightly superior to Tc-polyphosphate.


Subject(s)
Bone Neoplasms/diagnosis , Diphosphates , Phosphates , Radionuclide Imaging , Technetium , Blood Proteins/metabolism , Bone and Bones/metabolism , Diphosphates/blood , Diphosphates/metabolism , Diphosphates/urine , Humans , Kinetics , Phosphates/blood , Phosphates/metabolism , Phosphates/urine , Protein Binding
SELECTION OF CITATIONS
SEARCH DETAIL
...